
About Transverse Medical
Transverse Medical is a Healthcare company based in Golden (United States) founded in 2011. Developer of a device to prevent stroke during transcatheter aortic valve replacement heart procedures. Transverse Medical has raised $26.77 million across 4 funding rounds. Its chief executive, as recorded, is Eric Goslau. Transverse Medical offers products and services including POINT-GUARDβ’. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Transverse Medical Inc. Its competitors include Emboline, Claret Medical and Invictus Medical; 3 of its 3 listed competitors have raised funding.
Company details
Transverse Medical was founded in 2011 and is headquartered in Golden, United States. The company operates in the medical device sector, focusing on cardiovascular technologies. A cerebral embolic protection device known as Point Guard is developed to capture and remove debris particles during transcatheter aortic valve replacement and other structural heart procedures. This approach is intended to reduce stroke risks associated with such interventions.
- Headquarters Golden, United States
- SectorsHealthcare
- Website transversemedical.com
- Social LinkedIn
- Legal Name Transverse Medical Inc.
- Total Equity Funding$26.77M (USD)
in 4 rounds
- Latest Funding Round$10M (USD), Series B
Apr 2025
Products & Services of Transverse Medical
Transverse Medical offers a comprehensive portfolio of products and services, including POINT-GUARD™.
Protects the brain from embolic debris during heart procedures to prevent strokes.
Funding Insights of Transverse Medical
Transverse Medical has successfully raised a total of $26.77M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.77M
- Total Rounds 4
- Last Round Series B β $10M
- First Round $140,000
(Nov 2019)
All 4 funding rounds of Transverse Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $10M | Series B | β | β | β |
| Nov 2024 | $10M | Series B | β | β | β |
| Aug 2023 | $6.63M | Series A | β | β | β |
| Nov 2019 | $140,000 | Seed | β | β | β |
People of Transverse Medical
11 people are tracked at Transverse Medical (2 in leadership, 9 in board & advisors).
| Name | Role | Group |
|---|---|---|
Eric Goslau | CEO | Leadership |
Erin Spiegel | Vice President Regulatory And Quality (raqa) And Clinical Affairs | Leadership |
Stan Lapidus | Executive Advisor | Board & advisors |
Carl St. Bernard | Director | Board & advisors |
Ted Tarasow | Director & Co-Founder | Board & advisors |
Dan Estay | Director | Board & advisors |
Bill Goslau | Director | Board & advisors |
Samir Kapadia | Co-Chair Clinical Committee, US | Board & advisors |
Axel Linke | Clinical Committee Co-Chair, EU | Board & advisors |
David K. Stone | Director | Board & advisors |
Michael Reardon | Chief Medical Officer | Board & advisors |
Complete people profiles for Transverse Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Transverse Medical
3 dated milestones of Transverse Medical across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Transverse Medical is founded.
- Funding First funding round of $140K.
- Funding Latest funding round, Series B, of $10.0M.
Competitors of Transverse Medical
Transverse Medical has 3 listed competitors in our database, 3 of them funded. They include Emboline, Claret Medical and Invictus Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emboline.com | 2011 | Santa Cruz, United States | $81.92M | 16 | Aortic embolic protection devices are developed for cardiovascular procedures. | |
| claretmedical.com | 2009 | Santa Rosa, United States | $47.76M | 105 | Cerebral vascular protection systems for endovascular procedures are developed. | |
| invictusmed.com | 2010 | San Antonio, United States | $8.93M | Pediatric medical devices for infant care are developed and explored. |
Detailed competitors of Transverse Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Transverse Medical (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Transverse Medical
Complete news archive for Transverse Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transverse Medical
Transverse Medical was founded in 2011 and raised its 1st funding round 8 years after it was founded.
Transverse Medical is headquartered in Golden, United States. It is registered at Golden, Colorado, United States.
Eric Goslau is the CEO of Transverse Medical, as recorded in our data.
Transverse Medical is a funded company, having raised a total of $26.77M across 4 funding rounds to date. The company's 1st funding round was a Seed of $140K, raised on Nov 2019.
Transverse Medical was founded in 2011 and is headquartered in Golden, United States. The company operates in the medical device sector, focusing on cardiovascular technologies. A cerebral embolic protection device known as Point Guard is developed to capture and remove debris particles during transcatheter aortic valve replacement and other structural heart procedures. This approach is intended to reduce stroke risks associated with such interventions.
Transverse Medical's top competitors include Emboline, Claret Medical and Invictus Medical.
Transverse Medical offers POINT-GUARDβ’.
Transverse Medical operates through Transverse Medical Inc..
